Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Application of fractional factorial designs to study drug combinations.

Jaynes J, Ding X, Xu H, Wong WK, Ho CM.

Stat Med. 2013 Jan 30;32(2):307-18. doi: 10.1002/sim.5526. Epub 2012 Aug 1.

2.

Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.

Huang WY, Su YH, Yao HW, Ling P, Tung YY, Chen SH, Wang X, Chen SH.

J Gen Virol. 2010 Mar;91(Pt 3):591-8. doi: 10.1099/vir.0.016964-0. Epub 2009 Nov 11.

PMID:
19906941
4.

[Research of suppression of the herpes simplex virus reproduction with drug resistance by combination phosphite of acycloguanosine with some antiherpetic drugs].

Andronova VL, Jasko MV, Kukhanova MK, Skoblov YS, Deryabin PG, Galegov GA.

Vopr Virusol. 2014;59(6):32-5. Russian.

PMID:
25929034
6.

Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity.

Ding X, Sanchez DJ, Shahangian A, Al-Shyoukh I, Cheng G, Ho CM.

Int J Nanomedicine. 2012;7:2281-92. doi: 10.2147/IJN.S27540. Epub 2012 May 10.

7.

Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells.

Pierce AT, DeSalvo J, Foster TP, Kosinski A, Weller SK, Halford WP.

J Gen Virol. 2005 Sep;86(Pt 9):2421-32.

8.

Efficacy of Cafon gel on cutaneous infection with herpes simplex virus (HSV)-2 and acyclovir-resistant HSV in mice.

Yoshida Y, Yamamura J, Sato H, Koyasu M, Obara Y, Sekiguchi H, Kawana T, Shiraki K.

J Dermatol Sci. 1996 Dec;13(3):237-41.

PMID:
9023706
9.
10.

CMX001 potentiates the efficacy of acyclovir in herpes simplex virus infections.

Prichard MN, Kern ER, Hartline CB, Lanier ER, Quenelle DC.

Antimicrob Agents Chemother. 2011 Oct;55(10):4728-34. doi: 10.1128/AAC.00545-11. Epub 2011 Jul 25.

11.

In vitro and in vivo activity of eugenol on human herpesvirus.

Benencia F, Courrèges MC.

Phytother Res. 2000 Nov;14(7):495-500.

PMID:
11054837
12.

Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.

Duan J, Liuzzi M, Paris W, Lambert M, Lawetz C, Moss N, Jaramillo J, Gauthier J, Déziel R, Cordingley MG.

Antimicrob Agents Chemother. 1998 Jul;42(7):1629-35.

13.

Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1.

Dávola ME, Mazaira GI, Galigniana MD, Alché LE, Ramírez JA, Barquero AA.

Antiviral Res. 2015 Oct;122:55-63. doi: 10.1016/j.antiviral.2015.08.002. Epub 2015 Aug 8.

PMID:
26259812
15.

Antiviral effect of chinonin against herpes simplex virus.

Jiang J, Li S, Li M, Xiang J.

J Huazhong Univ Sci Technolog Med Sci. 2004;24(5):521-4.

PMID:
15641710
16.
17.

Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.

Schuhmacher A, Reichling J, Schnitzler P.

Phytomedicine. 2003;10(6-7):504-10.

PMID:
13678235
18.

2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.

Strand M, Islam K, Edlund K, Oberg CT, Allard A, Bergström T, Mei YF, Elofsson M, Wadell G.

Antimicrob Agents Chemother. 2012 Nov;56(11):5735-43. doi: 10.1128/AAC.01072-12. Epub 2012 Aug 20.

19.
20.

Herpes simplex virus resistance to acyclovir: clinical relevance.

Pottage JC Jr, Kessler HA.

Infect Agents Dis. 1995 Sep;4(3):115-24. Review.

PMID:
8548189

Supplemental Content

Support Center